Log in to your Inderes Free account to see all free content on this page.
Scandinavian ChemoTech
3.85 SEK
0.00 %
Less than 1K followers
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Scandinavian ChemoTech
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.5 | 2.0 | 6.6 | 2.5 | 3.8 | 3.3 | 2.6 | 12.3 |
| EBITDA | -2.7 | -2.5 | -10.7 | -2.1 | -4.1 | -0.6 | -1.6 | -4.5 |
| EBIT | -3.2 | -3.1 | -12.8 | -2.6 | -4.6 | -1.1 | -2.1 | -6.5 |
| EBIT-% | -212.0 % | -150.0 % | -194.8 % | -104.0 % | -119.3 % | -31.9 % | -80.9 % | -52.6 % |
| Profit before taxes | -3.2 | -3.6 | -13.7 | -3.3 | -0.9 | -1.3 | -2.5 | -8.1 |
| Net income | -3.2 | -3.2 | -13.7 | -3.3 | -0.9 | -1.3 | -2.5 | -8.1 |
Login required
This content is only available for logged in users